Biogen to Host Investor Webcasts from Clinical Trials on Alzheimer?s Disease (CTAD) Congress on December 5, 2019

Biogen to Host Investor Webcasts from Clinical Trials on Alzheimer?s Disease (CTAD) Congress on December 5, 2019
/

CAMBRIDGE, Mass., Nov. 04, 2019 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) today announced it will host live webcasts of its oral presentation and a Q&A session related to its Alzheimer?s disease investigational therapy, aducanumab, at the upcoming Clinical Trials on Alzheimer?s Disease (CTAD) annual congress in San Diego, California.??